NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹6,351 Cr | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr |
What is the latest Appropriations of NATCO PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹6,351 Cr |
| Mar2024 | ₹4,681 Cr |
| Mar2023 | ₹3,382 Cr |
| Mar2022 | ₹2,738 Cr |
| Mar2021 | ₹2,680 Cr |
How is Appropriations of NATCO PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,351 Cr | 35.69 | |
| Mar2024 | ₹4,681 Cr | 38.40 | |
| Mar2023 | ₹3,382 Cr | 23.51 | |
| Mar2022 | ₹2,738 Cr | 2.17 | |
| Mar2021 | ₹2,680 Cr | - | |
Compare Appropriations of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,805.6 Cr | -0.8% | -4% | 0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.8% |
-4% |
0.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses